✦ LIBER ✦

Multicenter, randomized, open-label study of the safety and efficacy of histamine dihydrochloride and interferon alpha-2b for the treatment of chronic hepatitis C: 48-week results

✍ Scribed by Y. Lurie; S. Hyle; K. Gehlsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

43 A multicenter, randomized, open-label

✍ H. Zhao; C.-W. Si; L. Wei; M.-B. Wan; Y.-K. Ying; J.-L. Hou; J.-Q. Niu; G.-Q. Wa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A phase II study of the combination of h

✍ Lurie, Yoav; Hyle, Sandy; Gehlsen, Kurt R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Safety and efficacy of pegylated interfe

✍ Voigt, Esther; Schulz, Christian; Klausen, Gerd; Goelz, Joachim; Mauss, Stefan; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 258 KB

58 RANDOMIZED, OPEN-LABEL, 12-WEEK COMPA

✍ Z. Krastev; I. Kotzev; K. Tchernev; A. Rigney; D. Nikolovska; B. Vladimirov; F.A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Multicenter, randomized, open-label stud

✍ Dieterich, Douglas T.; Sulkowski, Mark S.; Felizarta, Franco A.B.; Slim, Jihad; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 178 KB

[54] PEGINTERFERON-ALPHA-2a PLUS ADEFOVI

✍ P. Piccolo; I. Lend; D. Di Paolo; C. Telesca; L. DeMelia; O. Sorbello; F. Bandie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 143 KB